Поиск
Закладки
Озвучить текст Озвучить книгу
Изменить режим чтения
Изменить размер шрифта
Оглавление
Для озвучивания и цитирования книги перейдите в режим постраничного просмотра.
Нарушение обмена серосодержащих аминокислот (гомоцистинурия)

Список литературы

  1. Weber Hoss G.R., Poloni S., H. J Blom et al. Three Main Causes of Homocystinuria: CBS, cblC and MTHFR Deficiency. What do they Have in Common? // J. Inborn Errors Metab. Screen. FapUNIFESP (SciELO), 2019. Vol. 7.
  2. Семячкина А.Н. et al. Клинико-генетические аспекты и патогенетические механизмы классической гомоцистинурии у детей // Российский вестник перинатологии и педиатрии. Общество с ограниченной ответственностью «Национальная педиатрическая академия науки и инноваций», 2013. Vol. 58, № 3.
  3. Froese DS et al. Mutation Update and Review of Severe Methylenetetrahydrofolate Reductase Deficiency // Hum. Mutat. Hum Mutat, 2016. Vol. 37, № 5. P. 427–438.
  4. Sacharow S.J., Picker J.D., Levy H.L. Homocystinuria Caused by Cystathionine Beta- Synthase Deficiency // GeneReviews®. University of Washington, Seattle.
  5. Morris AA, Kožich V, Santra S et al. Guidelines for the diagnosis and management of cystathionine beta-synthase deficiency // J. Inherit. Metab. Dis. J Inherit Metab Dis, 2017. Vol. 40, № 1. P. 49–74.
  6. McCully KS. Homocysteine Metabolism, Atherosclerosis, and Diseases of Aging // Compr. Physiol. Compr Physiol, 2015. Vol. 6, № 1. P. 471–505.
  7. Sabrane I, Saoudi S, El Ikhloufi M, Elkaissoumi L, Taouri N, Amazouzi A C.O. Ectopia lentis in homocystinuria // J. Fr. Ophtalmol. J Fr Ophtalmol, 2019. Vol. 42, № 2. P. 219–220.
  8. Gus PI, Donis KC, Marinho D, Martins TF, de Souza CFM, Carloto RB, Leivas G S.I. Ocular manifestations in classic homocystinuria // Ophthalmic Genet. Ophthalmic Genet, 2021. Vol. 42, № 1. P. 71–74.
  9. Huemer, M., Diodato, D., Schwahn B. et al. Guidelines for diagnosis and management of the cobalamin-related remethylation disorders cblC, cblD, cblE, cblF, cblG, cblJ and MTHFR deficiency // J. Inherit. Metab. Dis. J Inherit Metab Dis, 2017. Vol. 40, № 1. P. 21–48.
  10. Weber Hoss GR, Sperb-Ludwig F, Schwartz IVD B.H. Classical homocystinuria: A common inborn error of metabolism? An epidemiological study based on genetic databases // Mol. Genet. Genomic Med. Wiley-Blackwell, 2020. Vol. 8, № 6.
  11. Zschocke J, Kebbewar M, Gan-Schreier H, Fischer C, Fang-Hoffmann J, Wilrich J, Abdoh G, Ben-Omran T, Shahbek N, Lindner M, Al Rifai H, Al Khal AL H.G. Molecular neonatal screening for homocystinuria in the Qatari population // Hum. Mutat. Hum Mutat, 2009. Vol. 30, № 6. P. 1021–1022.
  12. Gan-Schreier H, Kebbewar M, Fang-Hoffmann J, Wilrich J, Abdoh G, Ben-Omran T, Shahbek N, Bener A, Al Rifai H, Al Khal AL, Lindner M, Zschocke J H.G. Newborn population screening for classic homocystinuria by determination of total homocysteine from Guthrie cards // J. Pediatr. J Pediatr, 2010. Vol. 156, № 3. P. 427–432.
  13. Schimke RN et al. Homocystinuria. Studies of 20 families with 38 affected members. // JAMA. JAMA, 1965. Vol. 193, № 9. P. 711–719.
  14. Mudd SH. Vascular disease and homocysteine metabolism // N. Engl. J. Med. N Engl J Med, 1985. Vol. 313, № 12. P. 751–753.
  15. de Franchis R et al. Clinical aspects of cystathionine beta-synthase deficiency: how wide is the spectrum? The Italian Collaborative Study Group on Homocystinuria // Eur. J. Pediatr. Eur J Pediatr, 1998. Vol. 157 Suppl 2, № 2.
  16. Carson NA et al. Homocystinuria: clinical and pathological review of ten cases // J. Pediatr. J Pediatr, 1965. Vol. 66, № 3. P. 565–583.
  17. Abbott MH et al. Psychiatric manifestations of homocystinuria due to cystathionine beta- synthase deficiency: prevalence, natural history, and relationship to neurologic impairment and vitamin B6-responsiveness // Am. J. Med. Genet. Am J Med Genet, 1987. Vol. 26, № 4. P. 959–969.
  18. Skovby F., Gaustadnes M., Mudd S.H. A revisit to the natural history of homocystinuria due to cystathionine β-synthase deficiency // Mol. Genet. Metab. NIH Public Access, 2010. Vol. 99, № 1. P. 1.
  19. Harrison DA et al. Management of ophthalmic complications of homocystinuria // Ophthalmology. Ophthalmology, 1998. Vol. 105, № 10. P. 1886–1890.
  20. Mulvihill A et al. Ocular findings among patients with late-diagnosed or poorly controlled homocystinuria compared with a screened, well-controlled population // J. AAPOS Off. Publ. Am. Assoc. Pediatr. Ophthalmol. Strabismus. J AAPOS, 2001. Vol. 5, № 5. P. 311– 315.
  21. Kalil MAB, Donis KC, Poswar FO et al. Cardiovascular findings in classic homocystinuria // Mol. Genet. Metab. Reports. Elsevier, 2020. Vol. 25. P. 100693.
  22. Weber DR et al. Low bone mineral density is a common finding in patients with homocystinuria // Mol. Genet. Metab. Mol Genet Metab, 2016. Vol. 117, № 3. P. 351–354.
  23. Yap S et al. The intellectual abilities of early-treated individuals with pyridoxine- nonresponsive homocystinuria due to cystathionine beta-synthase deficiency // J. Inherit. Metab. Dis. J Inherit Metab Dis, 2001. Vol. 24, № 4. P. 437–447.
  24. Almuqbil MA et al. Revising the Psychiatric Phenotype of Homocystinuria // Genet. Med. 2019 218. Nature Publishing Group, 2019. Vol. 21, № 8. P. 1827–1831.
  25. Hidalgo Mazzei D et al. A forgotten lethal psychosis: a case report // Eur. Child Adolesc. Psychiatry. Eur Child Adolesc Psychiatry, 2014. Vol. 23, № 4. P. 235–238.
  26. Collins JE, Brenton DP. Pancreatitis and homocystinuria // J. Inherit. Metab. Dis. J Inherit Metab Dis, 1990. Vol. 13, № 2. P. 232–233.
  27. Ilan Y et al. Gastrointestinal involvement in homocystinuria // J. Gastroenterol. Hepatol. J Gastroenterol Hepatol, 1993. Vol. 8, № 1. P. 60–62.
  28. Patil RV et al. Chronic Pancreatitis in Homocystinuria // Indian Pediatr. 1995. Vol. 32(4). P. 469–470.
  29. Hong HS, Lee HK, Kwon KH. Homocystinuria presenting with portal vein thrombosis and pancreatic pseudocyst: a case report // Pediatr. Radiol. Pediatr Radiol, 1997. Vol. 27, № 10. P. 802–804.
  30. Makins RJ, Gertner DJ, Lee PJ. Acute pancreatitis in homocystinuria // J. Inherit. Metab. Dis. J Inherit Metab Dis, 2000. Vol. 23, № 2. P. 190–191.
  31. Batra S. Chronic relapsing pancreatitis // Clin. Pediatr. (Phila). Clin Pediatr (Phila), 2001. Vol. 40, № 2. P. 99–100.
  32. Gales A, Masingue M, Millecamps S et al. Adolescence/adult onset MTHFR deficiency may manifest as isolated and treatable distinct neuro-psychiatric syndromes // Orphanet J. Rare Dis. 2018. BioMed Central, 2018. Vol. 13, № 1. P. 1–8.
  33. Huemer M, Mulder-Bleile R, Burda P et al. Clinical pattern, mutations and in vitro residual activity in 33 patients with severe 5, 10 methylenetetrahydrofolate reductase (MTHFR) deficiency // J. Inherit. Metab. Dis. J Inherit Metab Dis, 2016. Vol. 39, № 1. P. 115–124.
  34. Sibani S et al. Characterization of six novel mutations in the methylenetetrahydrofolate reductase (MTHFR) gene in patients with homocystinuria - PubMed // Hum. Mutat. 2000. Vol. 15(3). P. 280–287.
  35. Bonafede L et al. Cobalamin C Deficiency Shows a Rapidly Progressing Maculopathy With Severe Photoreceptor and Ganglion Cell Loss // Invest. Ophthalmol. Vis. Sci. Invest Ophthalmol Vis Sci, 2015. Vol. 56, № 13. P. 7875–7887.
  36. Weisfeld-Adams JD et al. Ocular disease in the cobalamin C defect: a review of the literature and a suggested framework for clinical surveillance // Mol. Genet. Metab. Mol Genet Metab, 2015. Vol. 114, № 4. P. 537–546.
  37. Grangé S, Bekri S, Artaud-Macari E et al. Adult-onset renal thrombotic microangiopathy and pulmonary arterial hypertension in cobalamin C deficiency // Lancet (London, England). Lancet, 2015. Vol. 386, № 9997. P. 1011–1012.
  38. Kömhoff M, Roofthooft MT, Westra D et al. Combined pulmonary hypertension and renal thrombotic microangiopathy in cobalamin C deficiency // Pediatrics. Pediatrics, 2013. Vol. 132, № 2. P. 540–544.
  39. Rahmandar MH et al. Cobalamin C deficiency in an adolescent with altered mental status and anorexia // Pediatrics. Pediatrics, 2014. Vol. 134, № 6. P. e1709–e1714.
  40. Huemer M, Scholl-Bürgi S, Hadaya K et al. Three new cases of late-onset cblC defect and review of the literature illustrating when to consider inborn errors of metabolism beyond infancy // Orphanet J. Rare Dis. 2014 91. BioMed Central, 2014. Vol. 9, № 161. P. 1–12.
  41. Gizicki R, Robert MC, Gómez-López L et al. Long-term visual outcome of methylmalonic aciduria and homocystinuria, cobalamin C type // Ophthalmology. Ophthalmology, 2014. Vol. 121, № 1. P. 381–386.
  42. Huemer M, Bürer C, Ješina P et al. Clinical onset and course, response to treatment and outcome in 24 patients with the cblE or cblG remethylation defect complemented by genetic and in vitro enzyme study data // J. Inherit. Metab. Dis. J Inherit Metab Dis, 2015. Vol. 38, № 5. P. 957–967.
  43. Vilaseca MA, Vilarinho L, Zavadakova P et al. CblE type of homocystinuria: mild clinical phenotype in two patients homozygous for a novel mutation in the MTRR gene // J. Inherit. Metab. Dis. J Inherit Metab Dis, 2003. Vol. 26, № 4. P. 361–369.
  44. Pogliani L et al. Maternal methylenetetrahydrofolate reductase (MTHFR) homozygosity and neonatal outcome: follow-up of 42 pregnancies at risk // J. Child Neurol. J Child Neurol, 2010. Vol. 25, № 6. P. 701–704.
  45. Fernandes J, Saudubray JM, Van Den Berghe. Inborn Metabolic diseases. 3rd, Revised Edition Springer-Verlag Berlin Heidelberg 2000 https://link.springer.com/content/pdf/bfm%3A978-3-662-04285-4%2F1.pdf 46. Sriver CR et al. The metabolic and molecular bases of inherited disease. McGraw-Hill, New Yo…. 2001. Vol. 67, № 5. 611 p.
  46. Carrillo-Carrasco N, Venditti CP. Combined methylmalonic acidemia and homocystinuria, cblC type. II. Complications, pathophysiology, and outcomes // J. Inherit. Metab. Dis. J Inherit Metab Dis, 2012. Vol. 35, № 1. P. 103–114.
  47. Van Hove JL et al. Cobalamin disorder Cbl-C presenting with late-onset thrombotic microangiopathy // Am. J. Med. Genet. Am J Med Genet, 2002. Vol. 111, № 2. P. 195–201.
  48. D’Aco KE et al. Severe 5,10-methylenetetrahydrofolate reductase deficiency and two MTHFR variants in an adolescent with progressive myoclonic epilepsy // Pediatr. Neurol. Pediatr Neurol, 2014. Vol. 51, № 2. P. 266–270.
  49. Miousse IR et al. Clinical and molecular heterogeneity in patients with the cblD inborn error of cobalamin metabolism // J. Pediatr. J Pediatr, 2009. Vol. 154, № 4. P. 551–556.
  50. Refsum H et al. Facts and recommendations about total homocysteine determinations: an expert opinion // Clin. Chem. Clin Chem, 2004. Vol. 50, № 1. P. 3–32.
  51. Stabler SP, Lindenbaum J, Allen RH. Elevation of serum cystathionine levels in patients with cobalamin and folate deficiency - PubMed // Blood. 1993. Vol. 15, № 81(12). P. 3404–3413.
  52. Stabler SP et al. Metabolic profiling of total homocysteine and related compounds in hyperhomocysteinemia: utility and limitations in diagnosing the cause of puzzling thrombophilia in a family // JIMD Rep. JIMD Rep, 2013. Vol. 11. P. 149–163.
  53. Fowler B. Genetic defects of folate and cobalamin metabolism // Eur J Pediatr . 1998. Vol. 157. P. 60–66.
  54. Moat SJ, Bonham JR, Tanner MS et al. Recommended approaches for the laboratory measurement of homocysteine in the diagnosis and monitoring of patients with hyperhomocysteinaemia // Ann. Clin. Biochem. Ann Clin Biochem, 1999. Vol. 36 ( Pt 3), № 3. P. 372–379.
  55. Barić I et al. Consensus recommendations for the diagnosis, treatment and follow-up of inherited methylation disorders // J. Inherit. Metab. Dis. J Inherit Metab Dis, 2017. Vol. 40, № 1. P. 5–20.
  56. Qin X et al. Interaction of serum vitamin B12 and folate with MTHFR genotypes on risk of ischemic stroke // Neurology. Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology, 2020. Vol. 94, № 11. P. e1126–e1136.
  57. Coppola A et al. Homocysteine, coagulation, platelet function, and thrombosis // Semin. Thromb. Hemost. Semin Thromb Hemost, 2000. Vol. 26, № 3. P. 243–254.
  58. Pitchaiah Mandava. Homocystinuria/Homocysteinemia: Overview, Pathophysiology, Epidemiology [Electronic resource]. 2018. URL: https://emedicine.medscape.com/article/1952251-overview (accessed: 19.08.2021).
  59. Saito M, Marumo K. The Effects of Homocysteine on the Skeleton // Curr. Osteoporos. Rep. Curr Osteoporos Rep, 2018. Vol. 16, № 5. P. 554–560.
  60. Lim JS, Lee DH. Changes in bone mineral density and body composition of children with well-controlled homocystinuria caused by CBS deficiency // Osteoporos. Int. Osteoporos Int, 2013. Vol. 24, № 9. P. 2535–2538.
  61. Allen J et al. Plasma methionine concentrations and incidence of hypermethioninemic encephalopathy during infancy in a large cohort of 36 patients with classical homocystinuria in the Republic of Ireland // JIMD Rep. JIMD Rep, 2019. Vol. 47, № 1. P. 41–46.
  62. Sellos-Moura M, Glavin F., Lapidus D. et al. Prevalence, characteristics, and costs of diagnosed homocystinuria, elevated homocysteine, and phenylketonuria in the United States: a retrospective claims-based comparison // BMC Heal. Serv. Res. 2020 201. BioMed Central, 2020. Vol. 20, № 1. P. 1–11.
  63. Iranpour P., Karamifar N., As’adi K. Homocystinuria, typical brain MRI findings // J. Belgian Soc. Radiol. Ubiquity Press, 2010. Vol. 93, № 6. P. 322.
  64. Li CQ et al. Brain Magnetic Resonance Imaging Findings in Poorly Controlled Homocystinuria // J. Radiol. Case Rep. J Radiol Case Rep, 2018. Vol. 12, № 1. P. 1–8.
  65. Stephen JX Murphy, David J. Werring. Stroke: causes and clinical features // Medicine (Abingdon). Elsevier, 2020. Vol. 48, № 9. P. 561.
  66. Tsina EK et al. Maculopathy and retinal degeneration in cobalamin C methylmalonic aciduria and homocystinuria // Arch. Ophthalmol. (Chicago, Ill. 1960). Arch Ophthalmol, 2005. Vol. 123, № 8. P. 1143–1146.
  67. Ricci D et al. Assessment of visual function in children with methylmalonic aciduria and homocystinuria // Neuropediatrics. Neuropediatrics, 2005. Vol. 36, № 3. P. 181–185.
  68. Wang C et al. The MTHFR polymorphism affect the susceptibility of HCC and the prognosis of HCC liver transplantation // Clin Transl Oncol. Clin Transl Oncol, 2018. Vol. 20, № 4. P. 448–456.
  69. Chawla YK, Bodh V. Portal vein thrombosis // J. Clin. Exp. Hepatol. J Clin Exp Hepatol, 2015. Vol. 5, № 1. P. 22–40.
  70. Voskoboeva E et al. Homocystinuria due to cystathionine beta-synthase (CBS) deficiency in Russia: Molecular and clinical characterization // Mol. Genet. Metab. Reports. Elsevier, 2018. Vol. 14. P. 47–54.
  71. Yap S. Homocystinuria due to cystathionine β-synthase deficiency. 2003.
  72. Михайлова С.В., Захарова Е.Ю., Петрухин А.С. Нейрометаболические заболевания у детей и подростков. Диагностика и подходы к лечению. Москва, издательство . ―Литтерра,‖ 2019. 34–36 p.
  73. Ames EG et al. A cautionary tale of pyridoxine toxicity in cystathionine beta-synthase deficiency detected by two-tier newborn screening highlights the need for clear pyridoxine dosing guidelines // Am J Med Genet A . Am J Med Genet A, 2020. Vol. 182, № 11. P. 2704–2708.
  74. Yap S. Classical homocystinuria – newborn screening with early treatment effectively prevents complications // Hamdan Med. J. Hamdan Medical Journal, 2012. Vol. 5, № 3.
  75. Gowda M., Tanigasalam V, Thiagarajan M et al. Homocystinuria due to a Novel Mutation in MTHFR Gene: A Rare Cause of Non-Immune Hydrops Fetalis // Obstet. Gynecol. Int. J. MedCrave Group, LLC, 2018. Vol. 9, № 1. P. 60–61.
  76. Баранов АА, Намазова-Баранова ЛС, Боровик ТЭ и lдр. Диетотерапия при наследственных болезнях аминокислотного обмена Методическое письмо. // Москва. 2013. 97 p.
  77. Kumar T, Sharma GS, Singh LR. Homocystinuria: Therapeutic approach // Clin Chimca Acta. Clin Chim Acta, 2016. Vol. 458. P. 55–62.
  78. Turgal M. et al. Methylenetetrahydrofolate Reductase Polymorphisms and Pregnancy Outcome // Geburtshilfe Frauenheilkd. Thieme Medical Publishers, 2018. Vol. 78, № 9. P. 871.
  79. Vilaseca MA, Cuartero ML, Martinez de Salinas M. Two successful pregnancies in pyridoxine-nonresponsive homocystinuria // J. Inherit. Metab. Dis. J Inherit Metab Dis, 2004. Vol. 27, № 6. P. 775–777.
  80. Anaesthesia recommendations for patients suffering from Homocystinuria // OrphanAnesthesia.
  81. https://apps.who.int/iris/handle/10665/43737?locale-attribute=ru& [Electronic resource].
  82. Björck-Åkesson E, Wilder J, Granlund M et al. The International Classification of Functioning, Disability and Health and the version for children and youth as a tool in child habilitation/early childhood intervention--feasibility and usefulness as a common language and frame of reference for practice // Disabil. Rehabil. Disabil Rehabil, 2010. Vol. 32 Suppl 1, № SUPPL. 1.
  83. Richard L. Harvey, Richard F. Macko, Joel Stein et al. Stroke Recovery and Rehabilitation. Demos Medical Publishing, 2008. Vol. 20. 797 p.
  84. Morrison T., Bösch F., Landolt M.A. et al. Homocystinuria patient and caregiver survey: experiences of diagnosis and patient satisfaction // Orphanet J. Rare Dis. 2021 161. BioMed Central, 2021. Vol. 16, № 1. P. 1–12.
  85. McKusick VA, Hall JG, Char F. The clinical and genetic characteristics of homocystinuria. In: Carson NAJ, Raine DN, editors. // Inherit. Disord. Sulphur Metab. Edinburgh Churchill Livingstone. 1971.
  86. Beck N., Applegate C. Elements of genetic counseling for inborn errors of metabolism // Transl. Sci. Rare Dis. IOS Press, 2019. Vol. 4, № 3–4. P. 197–208.
  87. Betaine (anhydrous, not equivalent to betaine hydrochloride): Pediatric drug information/ UTD (октябрь 2021г). https://www.uptodate.com/contents/betaine-anhydrous-not- equivalent-to-betaine-hydrochloride-pediatric-drug- information?search=homocystinuria%20betain&source=search_result&selectedTitle=5~54& usage_type=default&display_rank=5
  88. Kaye, A.D., Jeha, G.M., Pham, A.D. et al. Folic Acid Supplementation in Patients with Elevated Homocysteine Levels. Adv Ther 37, 4149–4164 (2020).
  89. Thomas J.A. (2015) Homocystinuria: Diagnosis and Management. In: Bernstein L., Rohr F., Helm J. (eds) Nutrition Management of Inherited Metabolic Diseases. Springer, Cham. https://doi.org/10.1007/978-3-319-14621-8_14
  90. Semyachkina A, Voskoboeva E, Yablonskya M, Nikolaeva E (2018) Clinical and Molecular Characteristics of Russian Patients with Homocystinuria due to Cystathionine Beta-Synthase Deficiency. J Neurol Neurophysiol 9: 458. doi:10.4172/2155-9562.1000458
  91. Calvert SM, Rand RJ. A successful pregnancy in a patient with homocystinuria and a previous near-fatal postpartum cavernous sinus thrombosis. Br J Obstet Gynaecol. 1995 Sep;102(9):751-2
  92. Prasad C, Greenberg CR, Gilfix BM, MacGregor D, Shih VE, Bao L, Kraus JP. Reproductive fitness in maternal homocystinuria due to cystathionine beta-synthase deficiency. J Inherit Metab Dis. 2002 Aug;25(4):299-314. doi: 10.1023/a:1016502408305
  93. Pierre G, Gissen P, Chakrapani A, McDonald A, Preece M, Wright J. Successful treatment of pyridoxine-unresponsive homocystinuria with betaine in pregnancy. J Inherit Metab Dis. 2006 Oct;29(5):688-9
  94. Hart C, McNulty J, Cotter M, Al Jasmi F, Crushell E, Monavari AA. The challenges of pregnancy management in pyridoxine nonresponsive homocystinuria: The Irish experience. JIMD Rep. 2021 Jun 9;61(1):34-41
  95. https://grls.rosminzdrav.ru
  96. Crooke JW, Towers JF, Taylor WH. Management of patients with homocystinuria requiring surgery under general anaesthesia. A case report. Br J Anaesth. 1971 Jan;43(1):96-9
  97. Klein NP, Aukes L, Lee J, Fireman B, Shapira SK, Slade B, Baxter R, Summar M. Evaluation of immunization rates and safety among children with inborn errors of metabolism. Pediatrics. 2011 May;127(5):e1139-46 Pittet LF, Posfay-Barbe KM. Vaccination of immune compromised children-an overview for physicians. Eur J Pediatr. 2021 Jul;180(7):2035-2047

Для продолжения работы требуется Регистрация
На предыдущую страницу

Предыдущая страница

Следующая страница

На следующую страницу
Список литературы
На предыдущую главу Предыдущая глава
оглавление
Следующая глава На следующую главу

Оглавление

Данный блок поддерживает скрол*